AU2001259159A1 - Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters - Google Patents

Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters

Info

Publication number
AU2001259159A1
AU2001259159A1 AU2001259159A AU5915901A AU2001259159A1 AU 2001259159 A1 AU2001259159 A1 AU 2001259159A1 AU 2001259159 A AU2001259159 A AU 2001259159A AU 5915901 A AU5915901 A AU 5915901A AU 2001259159 A1 AU2001259159 A1 AU 2001259159A1
Authority
AU
Australia
Prior art keywords
treatment
skin damage
conjugated linoleic
fatty acid
acid esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259159A
Inventor
Nicholas V. Perricone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001259159A1 publication Critical patent/AU2001259159A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001259159A 2000-05-02 2001-04-25 Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters Abandoned AU2001259159A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/563,169 US6296861B1 (en) 1999-05-03 2000-05-02 Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
US09563169 2000-05-02
PCT/US2001/013402 WO2001082861A2 (en) 2000-05-02 2001-04-25 Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters

Publications (1)

Publication Number Publication Date
AU2001259159A1 true AU2001259159A1 (en) 2001-11-12

Family

ID=24249379

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259159A Abandoned AU2001259159A1 (en) 2000-05-02 2001-04-25 Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters

Country Status (3)

Country Link
US (1) US6296861B1 (en)
AU (1) AU2001259159A1 (en)
WO (1) WO2001082861A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7438896B2 (en) 1995-09-20 2008-10-21 N.V. Perricone Llc Method of skin care using lipoic and ascorbic acids
GB9918028D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
US6555573B2 (en) * 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
US20060198760A1 (en) * 2001-08-02 2006-09-07 General Electric Company Opto-acoustic sensor device and associated method
US20030105031A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Methods for the treatment of skin disorders
US6753325B2 (en) 2001-11-06 2004-06-22 The Quigley Corporation Composition and method for prevention, reduction and treatment of radiation dermatitis
US20030118536A1 (en) * 2001-11-06 2003-06-26 Rosenbloom Richard A. Topical compositions and methods for treatment of adverse effects of ionizing radiation
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
US7435725B2 (en) * 2001-11-06 2008-10-14 The Quigly Corporation Oral compositions and methods for prevention, reduction and treatment of radiation injury
FR2841101B1 (en) * 2002-06-21 2005-06-24 Oreal USE OF FATTY ACIDS FOR THE PREPARATION OF FOOD COMPLEMENTS USEFUL IN THE TREATMENT OF THE DISORDERS OF THE PILO-SEBACEE UNIT
TW200407172A (en) 2002-10-17 2004-05-16 Unilever Nv Scalp treatment
JP2006507291A (en) * 2002-10-25 2006-03-02 エッセンティア バイオシステムズ インク Modulating zinc levels to improve tissue properties
US7083813B2 (en) * 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US7306810B1 (en) 2002-11-25 2007-12-11 Piedmont Cosmeceuticals, Inc. Skin cream
US20050276766A1 (en) * 2003-10-01 2005-12-15 Skin Biology, Inc. Methods and compositions for increasing skin remodeling
US20050186231A1 (en) * 2004-02-19 2005-08-25 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization with substituted ureas against color degradation of personal care products
AU2005239968B2 (en) * 2004-05-11 2009-12-03 Auckland Uniservices Limited CLA-enriched milkfat and uses thereof
US7767713B2 (en) 2004-08-05 2010-08-03 Palo Alto Investors Linoleic acid active agents for enhancing probability of becoming pregnant
BRPI0608032B1 (en) 2005-03-12 2018-10-16 Unilever Nv hair and / or scalp care composition and use of an amino-oxo-indolylidene compound
NZ543486A (en) * 2005-11-10 2009-03-31 Fonterra Corporate Res And Dev Compositions of CIS-9, trans-11 conjugated linoleic acid and vaccenic acid and uses thereof
JP2009542587A (en) * 2006-07-07 2009-12-03 ▲張輝▼ How to use calcium polyenoate in the field of medical beauty
FR2918877A1 (en) * 2007-07-16 2009-01-23 Oreal Use of agent comprising precursor of ceramide based 6-hydroxy-4-sphingenine, or ascorbic acid analogues, allowing the increase of ceramide content in the lips, as protective agent for fragile lips, preferably the vermilion zone
EP1955692A1 (en) * 2007-01-12 2008-08-13 L'oreal Use of active agents for increasing the ceramide content of the lips, as a protection agent for fragile lips
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
KR20110130434A (en) * 2009-02-20 2011-12-05 디에스엠 아이피 어셋츠 비.브이. Composition comprising n2-(1-oxohexadecyl)-lysyl-valyl-lysine for treating rosacea and its symptoms
US9549550B2 (en) * 2009-10-30 2017-01-24 David Changaris Method and composition for long acting bacterial suppression on skin
US8609604B2 (en) 2009-12-28 2013-12-17 N.V. Perricone Llc Methods of improving the appearance of aging skin
US20110160144A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Formulations
US8580742B2 (en) 2010-03-05 2013-11-12 N.V. Perricone Llc Topical glutathione formulations for menopausal skin
US20110160143A1 (en) * 2009-12-28 2011-06-30 Perricone Nicholas V Topical Acyl Glutathione Psoriasis Compositions
JP2013515771A (en) 2009-12-28 2013-05-09 エヌ・ブイ・ペリコーン・リミテッド・ライアビリティ・カンパニー Topical acylglutathione formulation
US20110245183A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
US20110245182A1 (en) 2010-04-06 2011-10-06 Perricone Nicholas V Topical Uses of Szeto-Schiller Peptides
WO2012006107A2 (en) 2010-06-28 2012-01-12 Stemtide, Inc. Skin care compositions
US20120083452A1 (en) 2010-09-30 2012-04-05 Perricone Nicholas V Topical Anesthetic Uses of Szeto-Schiller Peptides
US8414869B2 (en) 2010-11-30 2013-04-09 N.V. Perricone Llc Melanin promoting topical composition
US8609618B2 (en) 2011-03-25 2013-12-17 N.V. Perricone Llc Topical palmitoyl glutathione formulations
WO2013091894A2 (en) 2011-12-21 2013-06-27 Flavin Dana Topical compositions
JP2023144523A (en) * 2022-03-28 2023-10-11 ピアス株式会社 Atopic dermatitis ameliorating agent, interleukin production inhibitor, and inhibitor of interleukin gene expression
CN115040501B (en) * 2022-06-06 2023-09-12 中国中医科学院广安门医院 Application of cis-13-octadecenoic acid or salt compound thereof in preparation of drugs for promoting healing of damaged skin and/or mucous membrane

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2474310A1 (en) 1980-01-25 1981-07-31 Oreal STABLE SOLUTION WITH OXIDATION OF VITAMIN F AND JOJOBA OIL AND COSMETIC COMPOSITIONS CONTAINING THE SAME
US5574063A (en) 1989-10-12 1996-11-12 Perricone; Nicholas V. Method and compositions for topical application of ascorbic acid fatty acid esters for treatment and/or prevention of skin damage
US5554647A (en) 1989-10-12 1996-09-10 Perricone; Nicholas V. Method and compositions for treatment and/or prevention of skin damage and aging
US5545398A (en) 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
US5709868A (en) * 1995-09-20 1998-01-20 Perricone; Nicholas V. Lipoic acid in topical compositions
US6019990A (en) * 1997-11-21 2000-02-01 Natural Nutrition Ltd. As Conjugated linoleic acid delivery system in cosmetic preparations
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition

Also Published As

Publication number Publication date
US6296861B1 (en) 2001-10-02
WO2001082861A3 (en) 2002-01-24
WO2001082861A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2001259159A1 (en) Treatment of skin damage using conjugated linoleic acid and ascorbyl fatty acid esters
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU6236900A (en) Method of preparing dimeric fatty acids and/or esters thereof
AU2002228992A1 (en) Bioactive compositions comprising conjugated linoleic acid glycerides and methods for producing bioactive conjugated linoleic acid
AU3843200A (en) Conjugated fatty acid esters
AU2001248699A1 (en) A pharmaceutical composition and method of treatment of diseases of cognitive dysfuntion in a mammal
AU6720500A (en) Use of conjugated linoleic acid (cla) for the topical treatment of cellulite
AU7880700A (en) Compositions and methods of treatment for skin conditions using extracts of turmeric
AU2001264161A1 (en) Production of conjugated linoleic and linolenic acids in plants
AU2091099A (en) Esters of conjugated linoleic acid or conjugated linolenic acid and uses thereof
AU2003223930A1 (en) Pharmaceutical use of boronic acids and esters thereof
AU2001286562A1 (en) Use of agaricus blazei murill to prevent or treat skin and other disorders
WO2002015938A3 (en) Testosterone ester formulation for human use
ZA200502613B (en) Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents
AU2058701A (en) Esters of vitamin D3 and uses thereof
HUP0303796A3 (en) Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
AU7222598A (en) Treatment of depression and anxiety using docosahexaenoic acid or natural antioxidants
AU2001259158A1 (en) Treatment of skin damage using acetyl carnitine and phosphatidylcholine and/or ascorbyl fatty acid esters
AU2634101A (en) Therapeutic preparations of highly unsaturated fatty acids
AU4666800A (en) Fatty acid esters of aromatic alcohols and their use in cosmetic formulations
AU2002343530A1 (en) Esters of aromatic alkoxylated alcohols and fatty carboxylic acids
AU2003271049A8 (en) Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin
AU2118701A (en) Sterol esters of conjugated linoleic acids and process for their production
AU6402700A (en) Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
AUPQ480399A0 (en) Unsaturated fatty acids and their uses in therapy